Randomized Phase IIa Clinical Trial in Parkinson ' s Disease Patients Using Pluripotent Adipose Stem Cells

Conditions: Parkinson Disease Interventions: Biological: PASC transplantation (25 million PASCs/patient); Biological: Control Sponsors: ClusterXStem-Costa Rica; Universidad de Costa Rica; University of California, Los Angeles Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials